SEC 13F Intelligence

Managers / Q1 2025 · view latest →

Frazier Life Sciences Management, L.P.

CIK 0001892134 · 1001 PAGE MILL ROAD, BUILDING 4, SUITE 200B, PALO ALTO, CA, 94304 · (650) 325-5156

Reported Value
$2.2B
Q1 2025
Positions
47
Filings on Record
18
2019–present window
Filed
May 15, 2025
original filing

Summary

Frazier Life Sciences Management, L.P. reported $2.2B in U.S.-listed holdings across 47 positions for Q1 2025.

Its largest position, Newamsterdam Pharma Company, represents 15.1% of the portfolio.

Compared with Q4 2024, the fund opened 4 new positions and exited 7.

Reported Value by Quarter

13F Reported Value
Q1 ’22: $1.2BQ1 ’22Q2 ’22: $1.1BQ3 ’22: $1.3BQ4 ’22: $1.61TQ4 ’22Q1 ’23: $1.4BQ2 ’23: $1.7BQ3 ’23: $1.5BQ3 ’23Q4 ’23: $1.9BQ1 ’24: $2.4BQ2 ’24: $2.1BQ2 ’24Q3 ’24: $2.5BQ4 ’24: $2.4BQ1 ’25: $2.2BQ1 ’25Q2 ’25: $2.5BQ3 ’25: $3.3BQ4 ’25: $3.7BQ4 ’25Q1 ’26: $3.9Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 68.8%Other: 18.9%ADR: 12.3%
  • Common Stock · 68.8% · $1.5B
  • Other · 18.9% · $413M
  • ADR · 12.3% · $269M

Quarter-over-Quarter Changes full breakdown →

Holdings — Q1 2025

Loading…
Export to Excel
#IssuerClass% PortfolioValue ↓Shares

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$3.9B38May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$3.7B40Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$3.3B47Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$2.5B49Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$2.2B47May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$2.4B50Feb 18, 202513F-HRchanges · EDGAR ↗
Q3 2024$2.5B53Nov 15, 202413F-HRchanges · EDGAR ↗
Q2 2024$2.1B49Aug 15, 202413F-HRchanges · EDGAR ↗
Q1 2024$2.4B50May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$1.9B49Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$1.5B52Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.7B48Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.4B49May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.61T44Feb 7, 2023RESTATEMENTchanges · EDGAR ↗
Q3 2022$1.3B43Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.1B41Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.2B42May 16, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.